Tech Company Financing Transactions
Argos Therapeutics Funding Round
Argos Therapeutics, based in Durham, secured $14.4 million from Forbion Capital Partners, Lumira Capital and TVM Capital.
Transaction Overview
Company Name
Announced On
9/30/2012
Transaction Type
Venture Equity
Amount
$14,378,100
Round
Undisclosed
Investors
Forbion Capital Partners (Sander Deventer)
Lumira Capital (Brian Underdown)
TVM Capital (Hubert Birner)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
4233 Technology Dr.
Durham, NC 27704
USA
Durham, NC 27704
USA
Phone
Website
Email Address
Overview
Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its Arcelis technology platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Abbey
Chief Financial Officer
Richard Katz
Chief Scientific Officer
Charles Nicolette
VP - Finance
Lori Harrelson
Browse more venture capital transactions:
Prev: 9/30/2012: Alltuition venture capital transaction
Next: 9/30/2012: MemSQL venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs